United States · Research startup
United States · Alloy Therapeutics, Inc.
Alloy Therapeutics, Inc.
Funding reportedLast round: Series E
About Alloy Therapeutics, Inc.
Alloy Therapeutics, Inc.
is a biotechnology ecosystem company founded in 2017, based in Boston, Massachusetts, with additional offices in Waltham, MA. The company operates a global network of labs in locations including Cambridge (UK), Basel (Switzerland), San Francisco (CA), and Athens (GA). Alloy Therapeutics focuses on empowering the scientific community to discover and develop better medicines through AI-driven platforms, integrated antibody discovery services, and proprietary technology licensing. The company offers a dual business model that includes licensing its technology platforms and providing bespoke discovery services across six therapeutic modalities: antibodies, bispecifics, TCR mimics, genetic medicines, cell therapies, and drug delivery. Key technology platforms include the ATX-GxTM Transgenic Mice Platform for monoclonal antibody discovery and the ATX-CLCTM Common Light Chain Platform for bispecific antibody engineering. Alloy Therapeutics serves a diverse clientele, including academic scientists, small and medium biotech firms, and large biopharmaceutical companies, collaborating with over 170 partners globally to advance drug discovery.
What company datasets say Alloy Therapeutics, Inc. raised
Funding, as reported
Founders and team
From Alloy Therapeutics, Inc.'s own website and the SEC filings it signed: 7 on the team.
- Simon FriedensohnCEO of Insights Division
- Jeff SwensonCFO, Alloy
- Joshua BrandtHead of Legal
- Leigh DoyleAssociate Director, UK Operations and Co-head Alloy UK
- Fabian B. HansenMr. Hansen was elected as a Director subsequent to the Date of First Sale.i
- Jay B. RosanelliExecutive Officeri
- Logan B. SnyderExecutive Officer, Directori
On the board, as filediAlex B. KolicichJason B. CammJason ColomaUlrik B. Nielsen
AdvisersRon AdnerPiotr B. Bobrowicz
The company, in detail
What they build
Known for
monoclonal antibodiesventure studiosbiotechnology researchbispecific antibodiesbiologics discoveryb2bchimeric antigen receptorsdrug discoverytcrhumanized transgenic mousebiotechnologyservicesimmunotherapyasocompany creationbiotech
Built with from their website
NetSuiteResiDocuSignJazzHRChatGPTiEXExchangerCloudFlare CDNMistTwilio SendGrid Email Marketing CampaignsReact
+8 more
RESTANSBASEGraphySpectroANGEL LMSAWS Trusted AdvisorSecuronix Security Operations and Analytics Platform
- Sector
- Research
- Industry code
- NAICS 541714, SIC 8731
- Region
- Massachusetts
- Revenue
- $36M a year, as listed
Research in United States
Startups like it
OpenAISan Francisco · founded 2011Raised
Retro BiosciencesRedwood City · founded 2021Raised
NewLimitSouth San Francisco · founded 2022Raised
PathosNew York · founded 2022Raised
Colossal BiosciencesDallas · founded 2021Raised
OratomicSouth PasadenaRaised
Beeline MedicinesStamford · founded 2025Raised
Element BiosciencesSan Diego · founded 2017Raised
Is this your company?
Add your raise, your deck and your story, and put Alloy Therapeutics, Inc. in front of investors. Or tell us what we have wrong.